Replies to post #41567 on Cel Sci Corporation (CVM)

[drkazmd65]

Interesting article - Thanks for sharing.

I'm a bit fuzzy on the author's interpretation on the Tumor Response section. He/she may be over-interpreting the pre-surgery responders a bit.

I don't see any indication in the abstract itself that suggests that some of the responders had complete disappearance of tumors. If that is true, even better of course. Just a simple shrinkage of tumors with 3 weeks of Multikine is definitely still a big benefit.

I especially liked the sections of the article where the author discusses the potential application of Multikine to other solid tumor types. Once Multikine is approved (assuming a successful BLA and review) for H&N cancers, it would be relatively easy (as the author points out) to set up some Phase II type tests for some of the types of breast cancer or maybe bone cancers with similar problems in treatment. If disfiguring surgery can be avoided, or if tumor masses can be shrunk before surgery, then the potential applications of Multikine could be quite extensive and lucrative.